Thurston Springer Miller Herd & Titak’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-600
Closed -$5.48K – 945
2026
Q2
$5.48K Buy
600
+300
+100% +$3.31K ﹤0.01% 973
2026
Q1
$3.44K Buy
+300
New +$3.96K ﹤0.01% 1102
2025
Q3
– Sell
-200
Closed -$2.23K – 1105
2025
Q2
$2.23K Buy
+200
New +$2.48K ﹤0.01% 1401

Other funds holding OFIX

Thurston Springer Miller Herd & Titak's OFIX Position: Q3 2026 in Review

Thurston Springer Miller Herd & Titak sold out of Orthofix Medical (OFIX) in Q3 2026, closing a stake of 600 shares — an estimated $5.48K sold.

Thurston Springer Miller Herd & Titak first reported a position in OFIX in Q2 2025 and held it in 3 quarters. The position peaked at $5.48K in Q2 2026. 98 funds tracked by Wall St. Rank hold OFIX as of Q3 2026.

  • Thurston Springer Miller Herd & Titak reported no remaining Orthofix Medical position as of Q3 2026 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 600 Orthofix Medical shares in Q3 2026, an estimated $5.48K.
  • Thurston Springer Miller Herd & Titak first reported a position in Orthofix Medical in Q2 2025 and held it in 3 quarters.
  • Thurston Springer Miller Herd & Titak's Orthofix Medical position peaked at $5.48K in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2026, filed 14 Oct 2026.